James W Shaw

International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials

T. Atkinson, J. Roydhouse, M. Pinto, 2023, Quality of Life Research.

Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off

T. Kohlmann, R. Norman, A. Pickard, 2020, Quality of Life Research.

Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group Report.

L. McLeod, O. Chassany, M. Schlichting, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

General population reference values for the Functional Assessment of Cancer Therapy‐Lung and PROMIS‐29

D. Cella, J. Penrod, N. Mohindra, 2023, Cancer medicine.

Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality

T. Kohlmann, A. Pickard, S. Walton, 2020, The European Journal of Health Economics.